Antiplatelet therapy in secondary stroke prevention

Author： Crawford K Michelle   Talbert Robert L  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.10, 2001-10, pp. : 1609-1613

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary and Secondary Stroke Prevention with Antiplatelet Drugs

By  

Current Pharmaceutical Design, Vol. 12, Iss. 10, 2006-04 ,pp. : 1293-1297

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events

By Ling Geoffrey  

American Journal of Cardiovascular Drugs, Vol. 9, Iss. 3, 2009-05 ,pp. : 197-209

Adis International

Access to resources Recommend Favorite

Aspirin and Antiplatelet Agent Resistance: Implications for Prevention of Secondary Stroke

By Greer David M.  

CNS Drugs, Vol. 24, Iss. 12, 2010-12 ,pp. : 1027-1040

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics of Antiplatelet Agents Used in the Secondary Prevention of Stroke

By Lenz T.L.   Wilson A.F.  

Clinical Pharmacokinetics, Vol. 42, Iss. 10, 2003-01 ,pp. : 909-920

Adis International

Access to resources Recommend Favorite

Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents

By  

Current Pharmaceutical Design, Vol. 18, Iss. 6, 2012-02 ,pp. : 850-860

Bentham Science Publishers

Access to resources Recommend Favorite